| Somogyi | Michael, U.S. Biochemist, 1883-1971. See: Somogyi effect, Somogyi method, Somogyi unit. (05 Mar 2000) |
|---|---|
| Somogyi effect | In diabetes, a rebound phenomenon of reactive hyperglycaemia in response to a preceding period of relative hypoglycaemia that has increased secretion of hyperglycaemic agents (epinephrine, norepinephrine, glucagon, cortisol, and growth hormone); described in diabetic patients given too much insulin who developed unrecognised nocturnal hypoglycaemia that made them hyperglycaemic (suggesting insufficient insulin) when tested the next morning. (05 Mar 2000) |
| Somogyi method | A measure of the level of activity of amylase in blood serum, as analyzed by means of the Somogyi method (the most frequently used procedure); one unit is equivalent to 1 mg of reducing sugar liberated as glucose per 100 ml of serum, when an aliquot of the latter is mixed with a standard starch substrate (plus sodium chloride for maximal activation) and incubated for a standard time; normal range is 80 to 150 unit's, but values are usually not regarded as clinically significant unless they are greater than 200. (05 Mar 2000) |
| Somogyi phenomenon | A rebound phenomenon of reactive hyperglycaemia following a period of relative hypoglycaemia, which may be subclinical and difficult to detect; the hyperglycaemia induces use of more insulin, thus aggravating the problem. Synonym: posthypoglycaemic hyperglycaemia. (05 Mar 2000) |
| Somogyi unit | A measure of the level of activity of amylase in blood serum, as analyzed by means of the Somogyi method (the most frequently used procedure); one unit is equivalent to 1 mg of reducing sugar liberated as glucose per 100 ml of serum, when an aliquot of the latter is mixed with a standard starch substrate (plus sodium chloride for maximal activation) and incubated for a standard time; normal range is 80 to 150 unit's, but values are usually not regarded as clinically significant unless they are greater than 200. (05 Mar 2000) |
| somatic gene therapy |
The delivery of genetically engineered genes to somatic cells in order to treat a disease.
출처: www.genpromag.com/Glossary~LETTER~S.html
|
|---|---|
| somatic mutation |
A non-heritable genetic change occurring within a somatic cell, also known as an acquired mutation.
출처: www.genpromag.com/Glossary~LETTER~S.html
|
| somnolence |
Sleepiness, a condition of semiconsciousness approaching coma.
출처: www.peteducation.com/dict_alpha_listing.cfm
|
| somatic cell hybridization |
Production of hybrid cells by fusion of two protoplasts with different genetic makeup. (2)
출처: ppathw3.cals.cornell.edu/glossary/Defs_S.htm
|
| somatosensory cortex |
The part of the brain responsible for processing stimulation coming from the skin, muscles, bones, tendons and joints. It plays a part in determining pain intensity.
출처: www.cnn.com/HEALTH/library/BN/00023.html
|